292 related articles for article (PubMed ID: 30991993)
1. Three-dimensional greyscale transrectal ultrasound-guidance and biopsy core preembedding for detection of prostate cancer: Dutch clinical cohort study.
van der Aa AAMA; Mannaerts CK; Gayet MCW; van der Linden JC; Schrier BP; Sedelaar JPM; Mischi M; Beerlage HP; Wijkstra H
BMC Urol; 2019 Apr; 19(1):23. PubMed ID: 30991993
[TBL] [Abstract][Full Text] [Related]
2. 3D Navigo™ versus TRUS-guided prostate biopsy in prostate cancer detection.
Gayet M; van der Aa A; Schmitz P; Beerlage HP; Schrier BP; Mulders PF; Mischi M; Wijkstra H
World J Urol; 2016 Sep; 34(9):1255-60. PubMed ID: 26847183
[TBL] [Abstract][Full Text] [Related]
3. Concordance of Gleason grading with three-dimensional ultrasound systematic biopsy and biopsy core pre-embedding.
van der Aa AAMA; Mannaerts CK; van der Linden H; Gayet M; Schrier BP; Mischi M; Beerlage HP; Wijkstra H
World J Urol; 2018 Jun; 36(6):863-869. PubMed ID: 29392409
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
5. Effect of targeted biopsy guided by elastic image fusion of MRI with 3D-TRUS on diagnosis of anterior prostate cancer.
Baco E; Rud E; Ukimura O; Vlatkovic L; Svindland A; Matsugasumi T; Bernhard JC; Rewcastle JC; Eggesbø HB
Urol Oncol; 2014 Nov; 32(8):1300-7. PubMed ID: 25189687
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis.
Martin PR; Cool DW; Romagnoli C; Fenster A; Ward AD
Med Phys; 2014 Jul; 41(7):073504. PubMed ID: 24989418
[TBL] [Abstract][Full Text] [Related]
7. Detection of prostate cancer with three-dimensional transrectal ultrasound: correlation with biopsy results.
Zhao HX; Zhu Q; Wang ZC
Br J Radiol; 2012 Jun; 85(1014):714-9. PubMed ID: 21712427
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Prostate HistoScanning as a Method for Targeted Biopsy in Routine Practice.
Glybochko PV; Alyaev YG; Amosov AV; Krupinov GE; Nir D; Winkler M; Ganzha TM
Eur Urol Focus; 2019 Mar; 5(2):179-185. PubMed ID: 28753891
[TBL] [Abstract][Full Text] [Related]
9. [Interest using 3D ultrasound and MRI fusion biopsy for prostate cancer detection].
Marien A; De Castro Abreu A; Gill I; Villers A; Ukimura O
Prog Urol; 2017 Sep; 27(10):521-528. PubMed ID: 28629785
[TBL] [Abstract][Full Text] [Related]
10. Utility of a 3-dimensional transrectal ultrasound-guided prostate biopsy system for prostate cancer detection.
Chen VH; Mouraviev V; Mayes JM; Sun L; Madden JF; Moul JW; Polascik TJ
Technol Cancer Res Treat; 2009 Apr; 8(2):99-104. PubMed ID: 19334790
[TBL] [Abstract][Full Text] [Related]
11. Results of a comparative analysis of magnetic resonance imaging-targeted versus three-dimensional transrectal ultrasound prostate biopsies: Size does matter.
Peltier A; Aoun F; Albisinni S; Marcelis Q; Ledinh D; Paesmans M; Lemort M; van Velthoven R
Scand J Urol; 2016 Jun; 50(3):144-8. PubMed ID: 26754860
[TBL] [Abstract][Full Text] [Related]
12. [Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer].
Maxeiner A; Stephan C; Fischer T; Durmus T; Kilic E; Asbach P; Haas M; Günzel K; Neymeyer J; Miller K; Cash H
Aktuelle Urol; 2015 Jan; 46(1):34-8. PubMed ID: 25519051
[TBL] [Abstract][Full Text] [Related]
13. MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men.
Yarlagadda VK; Lai WS; Gordetsky JB; Porter KK; Nix JW; Thomas JV; Rais-Bahrami S
Diagn Interv Radiol; 2018; 24(3):115-120. PubMed ID: 29770762
[TBL] [Abstract][Full Text] [Related]
14. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
[TBL] [Abstract][Full Text] [Related]
15. A comparison of prostate tumor targeting strategies using magnetic resonance imaging-targeted, transrectal ultrasound-guided fusion biopsy.
Martin PR; Cool DW; Fenster A; Ward AD
Med Phys; 2018 Mar; 45(3):1018-1028. PubMed ID: 29363762
[TBL] [Abstract][Full Text] [Related]
16. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
[TBL] [Abstract][Full Text] [Related]
17. Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy.
Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Pennisi M; Morgia G
Scand J Urol; 2017 Aug; 51(4):260-263. PubMed ID: 28513296
[TBL] [Abstract][Full Text] [Related]
18. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
[TBL] [Abstract][Full Text] [Related]
19. The combination of targeted and systematic prostate biopsies is the best protocol for the detection of clinically significant prostate cancer.
Fourcade A; Payrard C; Tissot V; Perrouin-Verbe MA; Demany N; Serey-Effeil S; Callerot P; Coquet JB; Doucet L; Deruelle C; Joulin V; Nonent M; Fournier G; Valeri A
Scand J Urol; 2018 Jun; 52(3):174-179. PubMed ID: 29463177
[TBL] [Abstract][Full Text] [Related]
20. [Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy].
Kesch C; Radtke JP; Distler F; Boxler S; Klein T; Hüttenbrink C; Hees K; Roth W; Roethke M; Schlemmer HP; Hohenfellner M; Hadaschik BA
Urologe A; 2016 Aug; 55(8):1071-7. PubMed ID: 27168038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
